XML 46 R34.htm IDEA: XBRL DOCUMENT v3.25.3
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense
Total share-based compensation expense was as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025202420252024
(In thousands)
Stock option expense$2,830 $3,417 $8,946 $10,443 
Restricted stock expense5,443 5,106 15,768 15,232 
Performance restricted stock unit expense4,643 4,220 10,515 9,232 
Total pre-tax expense$12,916 $12,743 $35,229 $34,907 
Schedule of Weighted Average Assumptions Used for Estimating Fair Values of Stock Options Granted The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the periods indicated:
Nine Months Ended
September 30, 2025
Year Ended December 31, 2024
Expected volatility22.7%28.2%
Expected term (years)5.05.0
Risk-free interest rate4.07%4.31%
Expected dividend yield0.70%0.62%
Black-Scholes-Merton fair value per stock option granted$46.21 $56.42 
Schedule of Stock Option Activity and Related Information
The following is a summary of the Company’s stock option activity and related information:
SharesWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life 
Aggregate
Intrinsic
Value
(In thousands)(Years)(In millions)
Outstanding at December 31, 20242,140 $114.33 
Granted267 176.08 
Exercised(203)106.79 
Forfeited(40)162.67 
Outstanding at September 30, 20252,164 $121.77 6.1$143.4 
Exercisable at September 30, 20251,659 $107.40 5.4$133.7 
Schedule of Nonvested Restricted Stock Activity and Related Information
The following is a summary of the Company’s non-vested restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested restricted stock outstanding at December 31, 2024277 $159.71 
Granted165 176.34 
Vested(135)150.79 
Forfeited(23)169.25 
Non-vested restricted stock outstanding at September 30, 2025284 $172.83 
The following is a summary of the Company’s non-vested performance restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested performance restricted stock outstanding at December 31, 2024235 $150.92 
Granted93 176.08 
Performance assumption change 1
8 134.69 
Vested(92)134.69 
Forfeited(3)164.75 
Non-vested performance restricted stock outstanding at September 30, 2025241 $166.09 
_________________________________________
1 Reflects the number of PRSUs above target levels based on performance metrics.